By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


SynteractHCR (Formerly Known As Synteract) 

5759 Fleet Street
Suite 100
Carlsbad  California  92008  U.S.A.
Phone: 760-268-8200 Fax: 760-929-1419


SynteractHCR is a full-service contract research organization with a successful two-decade plus track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development. SynteractHCR has conducted Phase I-IV studies on six continents and in more than 60 countries, offering expertise across multiple therapeutic areas and with notable depth in oncology, CNS, infectious disease, endocrinology, cardiovascular and respiratory, among other indications. With its “Shared Work – Shared Vision” philosophy and ICD+ approach, SynteractHCR provides customized services collaboratively and cost effectively, ensuring on-time delivery of quality data so clients get to decision points faster.

Key Statistics

Ownership: Subsidiary

Web Site: SynteractHCR
Employees: 350

Company News
SynteractHCR And The GOG Foundation Enter Into Agreement To Work Together In Supporting Gynecologic Oncology Research Studies 6/1/2017 12:02:18 PM
SynteractHCR Adds Another Three Senior Executives To Management Team With Both U.S. And International Clinical Trials Operations Experience 4/19/2017 12:10:22 PM
SynteractHCR Continues To Show International Clinical Trial Expertise By Participating In European Conferences This Spring 4/12/2017 6:30:11 AM
SynteractHCR Experts Slated To Speak At Leading Drug Development Conferences 2/1/2017 9:10:17 AM
SynteractHCR Release: Company Expands With Four New Experts Added To Global Leadership Team 1/18/2017 11:20:16 AM
SynteractHCR Expands Its Conference Speaking Engagements In October 10/11/2016 11:39:42 AM
SynteractHCR Continues To Bolster Senior Leadership Ranks To Match Global Growth 10/6/2016 10:22:51 AM
SynteractHCR Proves Industry Expertise Through Conference And Webinar Education 9/1/2016 12:57:05 PM
SynteractHCR Presenting And Exhibiting At DIA 2016 Annual Meeting In Philadelphia 6/14/2016 10:25:52 AM
Amulet Capital Partners, LP Announces Acquisition Of SynteractHCR 5/26/2016 11:37:20 AM